The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other most ...

Boston Scientific will purchase Ajax Health's Cortex and its OptiMap system to guide physicians performing AFib-treating ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

Boston Scientific has agreed to buy privately held medical- technology company Cortex from medical-device investor Ajax Health in a deal that bolsters its electrophysiology portfolio.

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.

Bank of America Securities analyst Travis Steed maintained a Buy rating on Boston Scientific (BSX – Research Report) today. The ...

Robust demand for non-urgent procedures, especially among older adults, have kept investor expectations heightened around the ...

Medical technology firms such as Becton, Boston Scientific and Abbott Laboratories have been benefiting from robust demand ...